Noni Safety: Liver Case Reports, Potassium and Interactions

Liver inflammation of the kind seen in the noni case reports
Liver inflammation of the kind seen in the noni case reports
Blood samples, where serum potassium is measured
Blood samples, where serum potassium is measured
Noni juice and fruit, a concentrated potassium source
Noni juice and fruit, a concentrated potassium source

This is the most important page in this section, and it is the one most often left out entirely. Noni juice is sold as a gentle fruit product, and for most healthy adults drinking a modest daily amount that is probably a fair description. But two documented hazards have been published in mainstream medical journals, and neither appears on a bottle: a series of acute hepatitis case reports from several independent centres in Austria, Germany, Croatia and the United States, and a high potassium content that has caused hyperkalaemia in a patient with impaired kidney function.

Neither of the two easy positions is honest. "Noni destroys your liver" overstates a small number of idiosyncratic cases against a very large number of uneventful consumers. Silence about them, which is what most noni pages offer, withholds the one piece of information that could actually change an outcome. This page gives both sides of the liver argument in full, states plainly what European regulators concluded, and then sets out the potassium problem, the drug interactions, and the warning signs of liver injury.

The key safety facts in brief. The liver case reports and the potassium data raise a concern for people with any liver disease, a history of drug-induced liver injury, chronic kidney disease or dialysis, or hyperkalaemia (high blood potassium) from any cause; there is no safety data for pregnancy or breastfeeding. Noni juice samples tested in a 2000 report held 56.3 mEq/L of potassium, which adds to the potassium kept in the body by an angiotensin-converting enzyme inhibitor (ACE inhibitor), an angiotensin receptor blocker (ARB), a potassium-sparing diuretic, trimethoprim or a potassium supplement. A 2004 report linked noni with warfarin resistance, and methotrexate or any other medication that stresses the liver adds a second liver risk. Yellow eyes or skin, dark urine, pale stools, itching, right-upper-abdominal pain, or unexplained nausea and fatigue are signs of liver injury that hospitals treat as urgent; in most published cases, liver tests returned to normal after the noni was stopped.

Table of Contents

  1. The Published Liver Case Reports
  2. What the Injury Looked Like
  3. The Manufacturer's Rebuttal and the Animal Data
  4. Weighing the Two Sides
  5. What European Food Safety Authority Actually Concluded
  6. Who the Liver Reports Raise Concerns For
  7. Warning Signs and the Tests That Check Them
  8. Potassium: The Concrete Hazard
  9. Who Is at Risk from the Potassium
  10. Drug Interactions
  11. Pregnancy, Breastfeeding and Children
  12. What Is Actually in the Bottle
  13. Monitoring, Surgery and Sensible Limits
  14. Putting the Risk in Proportion
  15. Key Research Papers
  16. Connections
  17. Featured Videos

The Published Liver Case Reports

These reports come from mainstream hepatology and gastroenterology journals, not from advocacy publications, and from several independent centres. That independence matters: a single case from a single group is anecdote, while consistent reports from unrelated hospitals are a signal.

Because published case reports are how idiosyncratic drug injury is discovered in the first place, "it is only case reports" is not the dismissal it sounds like. Rare unpredictable liver injury cannot be found any other way — it is invisible to trials of the size any supplement ever receives.

What the Injury Looked Like

The clinical picture across the reported cases is broadly consistent, which is itself part of the evidence:

The Manufacturer's Rebuttal and the Animal Data

Fairness requires giving the other side properly, because it consists of real published data and not merely of denial.

The authorship question. The authors of both papers were affiliated with the principal noni manufacturer, and that is disclosed in the papers. Disclosure is how science is supposed to work, and industry-funded toxicology is often the only toxicology that exists. But a manufacturer publishing a paper titled "Noni juice is not hepatotoxic" in response to independent clinicians reporting hepatitis is not a neutral referee, and a reader is entitled to weigh that. Both sets of papers are listed below, and each reads differently next to the other.

Weighing the Two Sides

Put plainly, the arguments line up like this.

Pointing toward causation:

  1. Multiple independent centres in different countries.
  2. A consistent hepatocellular pattern across cases.
  3. Improvement on withdrawal.
  4. At least one positive rechallenge in the published series.
  5. A plausible mechanism in a compound class known to contain hepatotoxins.

Pointing away from a simple causal story:

  1. A small number of cases against very large population exposure.
  2. Concomitant medications and supplements in several patients.
  3. Product heterogeneity — the "noni juice" in each case was a different blend.
  4. Negative animal toxicology at high doses.

The resolution that fits both sets of facts is idiosyncratic drug-induced liver injury: rare, unpredictable, not dose-proportional, dependent on individual susceptibility, and impossible to identify in advance. That is exactly the profile that produces a handful of severe cases amid millions of uneventful ones, and exactly the profile that negative animal studies cannot exclude, because the mechanism is host-dependent rather than intrinsic to the compound. Formal causality-assessment tools such as the Roussel Uclaf Causality Assessment Method (RUCAM) exist precisely for this problem. PubMed topic search.

Evidence tier: documented harm. Not proven for any individual, and not excluded by the negative animal data.

What European Food Safety Authority Actually Concluded

"EU-approved" appears constantly in noni marketing and is routinely misrepresented, so here is the accurate version.

Noni juice was assessed under the European Union's Novel Food framework and authorised for sale in 2003. After the hepatitis case reports appeared, the European Food Safety Authority was asked to look again, and its panel reviewed the reports and the available toxicological and consumption data. In substance, European Food Safety Authority (EFSA) concluded that noni juice was not expected to cause adverse liver effects in the general population at the levels of intake it assessed, while explicitly acknowledging the published case reports and the possibility that particular individuals may react idiosyncratically. Separate opinions have also addressed noni fruit purée, noni powder and noni leaves. The authorisations were generally maintained.

What that means:

The opinions themselves, rather than marketing summaries of them, are public at the European Food Safety Authority.

Who the Liver Reports Raise Concerns For

Idiosyncratic injury cannot be predicted, so the concern is greatest where an unpredictable liver risk is added to a liver that already has a problem or is already under load.

The concern applies most to people with:

The same concern applies to medications that load the liver: methotrexate, isoniazid, amiodarone, regular high-dose paracetamol/acetaminophen (see Acetaminophen Overdose), some antifungals, some antiretrovirals, and statins when liver tests are already borderline. Combining a predictable liver toxin with an unpredictable one adds two possible causes of injury; the Zagreb case occurred in a woman also on long-term phenobarbital.

Warning Signs and the Tests That Check Them

These are the signs of liver injury described in the case reports and in drug-induced liver injury generally. Hospitals treat jaundice, confusion and easy bruising as urgent. In most published cases, liver tests returned to normal after the noni was stopped.

The tests that check for it: a liver function panel (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, albumin), gamma-glutamyl transferase (GGT), and clotting studies if there is jaundice. A comprehensive metabolic panel covers most of this plus potassium and kidney function in one draw.

Why the noni needs naming. Herbal and dietary supplements are a leading cause of otherwise unexplained abnormal liver tests, and the diagnosis is routinely missed because nobody asks and nobody volunteers. In the Innsbruck and Munich cases, the noni came to light only when the patient was questioned about it. The ingredient list on the bottle shows what the product contains.

Potassium: The Concrete Hazard

This risk gets less attention than the liver signal, is far easier to predict, and in the wrong person is more immediately dangerous. Severe hyperkalaemia is one of the few electrolyte problems that can kill within hours.

Noni juice is high in potassium. Mueller, Scott, Sowinski and Prag reported in the American Journal of Kidney Diseases in 2000, under the title "Noni juice (Morinda citrifolia): hidden potential for hyperkalemia?", that the noni juice samples they tested contained 56.3 mEq/L of potassium (for potassium, mEq/L and mmol/L are the same), similar to orange juice and tomato juice. They described a man with chronic kidney failure who had been treating himself with noni juice and arrived at the clinic with hyperkalaemia, although he said he was keeping to a low-potassium diet. The authors wrote that herbal remedies "may be surreptitious sources of potassium in patients with renal disease." PubMed PMID: 10676732.

Why this matters physiologically. Healthy kidneys excrete surplus potassium effortlessly, and dietary potassium is genuinely good for most people — it is actively encouraged for blood pressure. In chronic kidney disease, especially advanced stages or dialysis, the kidney cannot dump the excess. Serum potassium climbs, and above roughly 6.0–6.5 mmol/L it interferes with cardiac conduction: bradycardia, widening of the QRS complex, and ultimately cardiac arrest. Early symptoms are vague — muscle weakness, fatigue, nausea, tingling — which is precisely the problem, because they resemble the complaints the juice was bought to treat. See Potassium Toxicity, Muscle Weakness, Numbness and Tingling and Heart Palpitations and Arrhythmia.

Two aggravating details specific to noni products. First, powders and capsules concentrate potassium along with everything else, and the amount is essentially never declared. Second, potassium content is never on the front label and often absent from the nutrition panel entirely, so a renal patient counting potassium has no way to count this.

Who Is at Risk from the Potassium

The potassium in noni juice is a concern in any amount for people whose kidneys or hormones cannot clear extra potassium:

Also at risk: anyone taking a drug that raises potassium.

With any of these drugs, the potassium in noni juice adds to the potassium the drug keeps in the body. Potassium and kidney function are both shown by a basic metabolic panel. Practical guidance on potassium in the diet is at the National Kidney Foundation, and the underlying nutrient page here is Potassium.

Drug Interactions

Beyond the potassium and liver interactions above:

Pregnancy, Breastfeeding and Children

What Is Actually in the Bottle

The formulation reality is a safety issue, not just a value-for-money one.

Monitoring, Surgery and Sensible Limits

For people with none of the concerns above who drink noni, the published information comes down to these points:

  1. Label doses are commonly 30–60 ml daily. "Loading phase" schedules have no evidence behind them and raise both the potassium load and hepatic exposure.
  2. It is a food, not a medicine. It has no established therapeutic dose because it has no established indication.
  3. Duration matters. The reported cases clustered at weeks to months of daily use (3 weeks to 3 months in the Innsbruck, Munich and Graz reports), particularly alongside other medication; liver tests are how injury in that window is found.
  4. It is a potassium-containing juice (56.3 mEq/L in the samples tested in 2000), which matters for anyone counting potassium.
  5. Surgery: the interval commonly cited for stopping supplements before an operation is two weeks — here the reasons are the theoretical anticoagulant and blood-pressure effects, and the general principle of not confounding perioperative liver tests.
  6. The warning signs above are signs of liver injury; in most published cases, liver tests returned to normal after the noni was stopped.
  7. A medication list that includes noni lets any clinician connect it with abnormal liver or potassium results.

Common minor effects, for completeness: the smell and taste cause nausea in some people, loose stools are reported, and the juice is acidic enough to aggravate reflux.

Putting the Risk in Proportion

Overstating this would be as much of a failure as omitting it, so here is the balanced statement.

For a healthy adult with normal liver and kidney function, on no interacting medication, drinking a modest daily amount of a blended noni juice, the absolute risk of serious harm appears low. Many millions of doses have been consumed and the published case series is small. That is a real fact and it belongs here.

But the risk-benefit arithmetic is unusual for noni, and it is the centre of the question. On the benefit side, as the pain, immune and energy pages set out, there is no established indication at all — not one condition for which noni has been shown to work in adequate human trials. On the risk side there is a documented, if rare, liver signal and a fully predictable potassium hazard. On these facts the benefit is unproven, while the risk, though small, is documented.

And for two groups the arithmetic is not close. For people with liver disease or chronic kidney disease, or taking a potassium-raising drug, the documented hazards apply directly, and the fact that most people drink it uneventfully does not change that. That asymmetry — near-zero demonstrated benefit for everyone, real hazard for identifiable groups — is the whole point of this page.

Key Research Papers

Each reference links to its PubMed record by its PubMed identifier (PMID).

  1. Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 2005;17(4):445-7. PubMed PMID: 15756098 — The index case.
  2. Stadlbauer V, Fickert P, Lackner C, Schmerlaib J, Krisper P, Trauner M, Stauber RE. Hepatotoxicity of NONI juice: report of two cases. World J Gastroenterol 2005;11(30):4758-60. PubMed PMID: 16094725 — With biopsy findings.
  3. Yuce B, Gulberg V, Diebold J, Gerbes AL. Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion 2006;73(2-3):167-70. PubMed PMID: 16837801
  4. Stadlbauer V, Weiss S, Payer F, Stauber RE. Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni). Am J Gastroenterol 2008;103(9):2406-7. PubMed PMID: 18844633
  5. West BJ, Jensen CJ, Westendorf J. Noni juice is not hepatotoxic. World J Gastroenterol 2006;12(22):3616-9. PubMed PMID: 16773722 — The manufacturer-affiliated rebuttal; read alongside items 1–4.
  6. West BJ, Su CX, Jensen CJ. Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit. J Toxicol Sci 2009;34(5):581-5. PubMed PMID: 19797868 — Animal, industry-affiliated.
  7. Mueller BA, Scott MK, Sowinski KM, Prag KA. Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis 2000;35(2):310-2. PubMed PMID: 10676732 — The potassium paper, and the most actionable citation on this page.
  8. Potterat O, Felten RV, Dalsgaard PW, Hamburger M. Identification of TLC markers and quantification by HPLC-MS of various constituents in noni fruit powder and commercial noni-derived products. J Agric Food Chem 2007;55(18):7489-94. PubMed PMID: 17696360 — Independent evidence of product variability.
  9. Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK, Anderson G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002;23(12):1127-41. PubMed PMID: 12466051 — The field's most-cited review; manufacturer-affiliated authorship.
  10. Yu EL, Sivagnanam M, Ellis L, Huang JS. Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni Berry) juice in a 14-year-old boy. J Pediatr Gastroenterol Nutr 2011;52(2):222-4. PubMed PMID: 21119544
  11. Mrzljak A, Kosuta I, Skrtic A, Kanizaj TF, Vrhovac R. Drug-induced liver injury associated with noni (Morinda citrifolia) juice and phenobarbital. Case Rep Gastroenterol 2013;7(1):19-24. PubMed PMID: 23467452
  12. Kim CJ, Duran Baez D, Ziyadin L, Huang SY, Reyes JV, Khan M, Brennan K. A case report: drug-induced liver injury from prolonged topical application of noni (Morinda citrifolia). J Investig Med High Impact Case Rep 2026;14:23247096261429179. PubMed PMID: 41805431
  13. Carr ME, Klotz J, Bergeron M. Coumadin resistance and the vitamin supplement "Noni". Am J Hematol 2004;77(1):103. PubMed PMID: 15307118 — Letter; no abstract.

PubMed Topic Searches

  1. PubMed: Morinda citrifolia hepatotoxicity — case reports
  2. PubMed: Noni juice, acute hepatitis and liver failure
  3. PubMed: Noni juice, potassium and renal insufficiency
  4. PubMed: Herb- and supplement-induced liver injury
  5. PubMed: Idiosyncratic liver injury, rechallenge and causality
  6. PubMed: Anthraquinones and hepatotoxicity
  7. PubMed: Drug-induced hyperkalaemia
  8. PubMed: Potassium restriction in kidney disease
  9. PubMed: Hyperkalaemia, ECG changes and emergency management
  10. PubMed: Herbal supplements and warfarin/INR
  11. PubMed: Novel-food safety assessment of noni juice
  12. PubMed: Traditional abortifacient herbs and pregnancy safety

External Resources

  1. European Food Safety Authority — the actual novel-food opinions on noni juice, purée, powder and leaves. Read these rather than summaries of them.
  2. LiverTox (NIH/NIDDK) — the free reference on drug- and herb-induced liver injury, and the right place to check any supplement before long-term use.
  3. National Kidney Foundation — potassium and diet in kidney disease.
  4. NIH National Center for Complementary and Integrative Health — plain-language botanical safety summaries.
  5. MedlinePlus — NIH consumer information on the drugs named above.

Connections


Safety note and disclaimer. This article is health education, not medical advice, and it cannot substitute for assessment by a clinician who knows your history and medications. Noni has no established therapeutic indication. The case reports and potassium data raise a concern for people with liver disease, a history of drug- or supplement-induced liver injury, chronic kidney disease, acute kidney injury or hyperkalaemia; there is no safety data for pregnancy, breastfeeding or children. The potassium in noni juice adds to the effect of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, potassium-sparing diuretics, trimethoprim, potassium supplements or salt substitutes and nonsteroidal anti-inflammatory drugs; warfarin resistance has been reported with noni; and methotrexate, immunosuppressants and other liver-toxic medications add liver risk. Jaundice, dark urine, pale stools, itching, right-upper-abdominal pain, or unexplained nausea and fatigue are signs of liver injury that hospitals treat as urgent. Palpitations, severe muscle weakness or collapse can signal hyperkalaemia, which hospitals treat as an emergency.

Back to Table of Contents